Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
Eur J Pharmacol. 2011 Nov 1;669(1-3):94-9. doi: 10.1016/j.ejphar.2011.07.042. Epub 2011 Aug 19.
The large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels modulate the retinal vascular tone, but question of whether the impairment of the channel function contributes to abnormalities of retinal circulation has not yet been completely elucidated. The purpose of this study was to examine effects of diabetes on the vasodilation induced by activation of BK(Ca) channels. Male Wistar rats were treated with streptozotocin and experiments were performed 2 weeks later. The streptozotocin-treated animals were given drinking water containing 5% d-glucose to shorten the term in the development of retinal vascular dysfunction. The retinal vascular responses were assessed by measuring diameter of retinal arterioles in the fundus images that were captured with an original fundus camera system. In non-diabetic rats, vasodilator effects of acetylcholine on retinal arterioles were significantly reduced by iberiotoxin, an inhibitor of BK(Ca) channels. However, the inhibitory effect of iberiotoxin was not observed in diabetic rats, and the responses to the BK(Ca) channel opener BMS-191011 were almost completely abolished. The retinal vasodilator response to acetylcholine, possibly an endothelium-derived hyperpolarizing factor-mediated response, observed after treatment with N(G)-nitro-l-arginine methyl ester and indomethacin was markedly reduced in diabetic rats. The responses to pinacidil, an opener of ATP-sensitive K(+) channels, were unchanged. These results suggest that the retinal vasodilator response mediated through mechanisms involving activation of BK(Ca) channels is diminished at the early stage of diabetes in rats. The impairment of BK(Ca) channel function may contribute to abnormal retinal hemodynamics in diabetes and consequently play an important role in the pathogenesis of diabetic retinopathy.
大电导钙激活钾(BK(Ca)) 通道调节视网膜血管张力,但通道功能障碍是否导致视网膜循环异常仍未完全阐明。本研究旨在探讨糖尿病对 BK(Ca) 通道激活诱导的血管舒张的影响。雄性 Wistar 大鼠用链脲佐菌素处理,2 周后进行实验。用含 5%d-葡萄糖的饮用水处理链脲佐菌素处理的动物,以缩短视网膜血管功能障碍发展的时间。通过拍摄眼底图像测量视网膜小动脉直径来评估视网膜血管反应,眼底图像由原始眼底相机系统拍摄。在非糖尿病大鼠中,BK(Ca) 通道抑制剂 iberiotoxin 显著降低乙酰胆碱对视网膜小动脉的血管舒张作用。然而,在糖尿病大鼠中未观察到 iberiotoxin 的抑制作用,BK(Ca) 通道开放剂 BMS-191011 的反应几乎完全被消除。在糖尿病大鼠中,乙酰胆碱引起的可能是内皮衍生超极化因子介导的反应的视网膜血管舒张反应明显降低。对 ATP 敏感性钾(BK(Ca)) 通道开放剂 pinacidil 的反应不变。这些结果表明,在糖尿病大鼠的早期阶段,通过激活 BK(Ca) 通道的机制介导的视网膜血管舒张反应减弱。BK(Ca) 通道功能障碍可能导致糖尿病视网膜异常血液动力学,并因此在糖尿病视网膜病变的发病机制中发挥重要作用。